Arkolith/Insider Trading/RCUS/Form 4

Tang Carolyn C.

General CounselArcus Biosciences, Inc. (RCUS) · full profile →Form 4 · filed Jun 12, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Option exercise(M)34K$2.57$88K185K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 11, 2026Option exercise(M)34K$2.57$88K0

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001836662-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML